Rayonier Advanced MaterialsRYAM
Recorded

Rayonier Advanced Materials 2026 Q3 Earnings Call

Review the key takeaways and the transcript of this earnings call.

PeriodQ3 2026Duration43 minParticipants7

Transcript

Preview the first fifteen paragraphs, organized by speaker.

Operator

Good morning, and welcome to the Rayonier Advanced Materials Third Quarter 2026 Earnings Conference Call. During today's presentation, all parties will be in a listen-only mode. Following the presentation, the conference will be open to questions, with instructions to follow at that time. As a reminder, this conference is being recorded. I would now like to turn the call over to your host, Cody LaCoste, Senior Manager of Investor Relations and Corporate Development. Thank you, Mr. LaCoste. You may begin.

Cody LaCosteSenior Manager of Investor Relations and Corporate Development

Good morning, and welcome to Rayonier Advanced Materials Third Quarter 2026 Earnings Conference Call. Joining me today are Dan Krawczyk, our President and Chief Executive Officer, and Marcus Moeltner, our Senior Vice President of Finance, Chief Financial Officer, and Treasurer. Last evening, we released our earnings report and accompanying presentation materials, which are available on our website at rayonieram.com. During today's discussion, we may make forward-looking statements subject to risks and uncertainties that could cause actual results to differ materially. These risks are outlined in our earnings release, SEC filings, and on slide two of the presentation. We will also reference certain non-GAAP financial measures to offer additional perspective on our operating performance. Reconciliations to the most directly comparable GAAP measures can be found in our presentation on slides 22 through 24. Thank you for joining us and for your continued interest in Rayonier.

Cody LaCosteSenior Manager of Investor Relations and Corporate Development

I'll now turn the call over to Dan.

Dan KrawczykPresident and CEO

Thanks, Cody. Good morning, everyone, and thank you for joining us. Before getting into the quarter and our path forward, shareholders have asked me for my impression of the business and how we're positioning this business with participants in the strategic review. Therefore, I believe it's important to share the perspectives I've gained since I first spoke to you on the Q2 earnings call. More than ever, I'm convinced that Rayonier Cellulose Specialties, or CS franchise, is an incredible, valuable, and profitable business. That value is being overshadowed by excess capacity filled with commodity products, which create ongoing losses within our High Purity Cellulose, or HPC business. The pricing dynamics make this clear. CS products have pricing power, but increased volume of lower-priced commodity products more than offset that strength, leaving the overall average cellulose pricing flat to declining.

Dan KrawczykPresident and CEO

This translates into profit performance that understates the true value of the overall business. We clearly need to change our production mix to favor CS products. I am highly confident in our ability to unlock this value and deliver exceptional returns to our shareholders. My time with customers and at our facilities has strengthened my conviction in the value of our Cellulose Specialties business. Customers depend on Rayonier's expertise to deliver product performance they cannot easily replicate elsewhere, including characteristics such as mouthfeel, reactivity, and color. Our products are specified into applications where those characteristics matter. We consistently transform a natural raw material, with all its inherent variability, into products with purity and technical characteristics customers need for their end products to perform as intended.

Dan KrawczykPresident and CEO

That value also extends through their manufacturing processes, where our reliable high-purity products deliver higher yields, require less capital, and generate less waste than lower-purity alternatives. Critical to our value proposition is that Rayonier brings the innovation to our CS customers need to differentiate their products and deliver performance that sets them apart from their competitors. These customers operate at the highest levels of their markets, where competition is fierce and innovation is critical to success. Our scientists understand cellulose at the molecular level and know how to translate that knowledge into production at scale to help our customers succeed. I saw this firsthand during customer visits, when our discussions quickly turned to what we could achieve together and their ambitions for more sustainable future products. Built over many decades, these relationships rest on a deep understanding of customer requirements.

Dan KrawczykPresident and CEO

They position Rayonier to share in our customers' future success and enable us to evolve with changing markets. Our past pricing and biomaterial strategies enabled important successes and laid a foundation we can build on. However, those strategies did not resolve the fundamental imbalance in our production mix. We must and will address it promptly. Our priorities are now clear: grow CS volumes, improve overall cellulose pricing by allocating a greater share of available capacity to CS, and execute tangible operating improvements at our mills. We must aggressively reduce the impact of commodity losses on the business. Our commercial team is working closely with customers to secure agreements that meet their future needs for reliable products performance and security of supply. We believe this renewed commitment and partnership will continue to grow and strengthen HPC. Growth is critical for our future performance, but we will not rely on growth alone.

Dan KrawczykPresident and CEO

We are prepared to move aggressively to rebalance our production mix without sacrificing the value our products command in the market. These opportunities to unlock this business's value are primarily within our control and are central to our discussions with interested parties in the strategic review. That does not mean decisions about the outcome of the strategic review have already been made. They have not. We are strengthening the business and positioning Rayonier to succeed under any review outcome and will be ready to execute. Turning to slide five. I am engaging as part of the strategic review with interested parties who share my conviction in the potential of this business and recognize the opportunity to build on our strengths. Our ambition is to transform Rayonier from a volatile, low-margin business constrained by the capital demands of its asset footprint and financial structure into a focused, high-margin Cellulose Specialties enterprise.

Dan KrawczykPresident and CEO

Highly engineered products must anchor more predictable earnings, supported by a footprint and financial structure that enable us to generate cash flow, reinvest in our future, and build lasting value for our shareholders. Turning to slide six, our investment thesis is grounded in demonstrated performance. Pricing improvements in our Cellulose Specialties franchise have driven some of its strongest results since the Tembec acquisition. The chart illustrates the price premium CS commands over commodity cellulose, or CC. In Q3, CS pricing was $2,227 per metric ton, compared with $825 per CC, a premium of 170%. GP Foley's late 2023 closure and Temiscaming's 2024 HPC idling tightened supply, reinforcing our pricing leadership strategy. Commodity markets operate differently. Pricing is driven by supply and demand, and not the differentiated product characteristics that support CS value.

Dan KrawczykPresident and CEO

New entrants have repeatedly added commodity capacity, putting pressure on industry economics and creating volatility in our results. High asset utilization alone is not enough. We must fill more of the available capacity with higher-value CS products to unlock the franchise's earning potential. Turning to slide seven, reducing commodity exposure is not a marginal adjustment. It is a fundamental shift in how we create shareholder value. The impact extends beyond lost EBITDA. The losses materially depress consolidated margins and absorb profits from our specialty business. Less commodity exposure can reduce earnings volatility, improve predictability, and make the contribution of CS more visible in our results. A strategy that delivers better quality earnings supports a stronger valuation and a better outcome for shareholders through the strategic review. We are not pursuing volume for its own sake.

Dan KrawczykPresident and CEO

We are pursuing a stronger earnings profile and a business that captures more of the value it creates. Turning to slide eight, Rayonier delivered another strong quarter in HPC. Earnings and total cellulose shipments improved sequentially, continuing the progress we have made since the first quarter. We also generated positive free cash flow. Construction is also underway on the Altamaha Green Energy, or AGE, project at Jesup, another example of creating long-term value from our existing infrastructure. Marcus will take you through the results in a few minutes. Before we get into that detail, I want to address the strategic review. I know shareholders are looking for a conclusion, and I want to explain both the progress we have made and the current expectations around timing. The review is well advanced. Interested parties have visited our plants, and detailed diligence has progressed well.

Dan KrawczykPresident and CEO

Our team and advisors continue to work through follow-up information requests and discussions with those parties. That work includes helping them understand the value of the CS franchise and the commercial and operating opportunities we see in the business. This process is a top priority, and I am directly involved with interested parties. The board's mandate to me is to maximize shareholder value. We are singularly focused on that objective, including managing our business for future success and discussing strategic alternatives to strengthen our CS franchise more quickly. The U.S. tariff on Canadian paperboard and resulting economic idling of Temiscaming have caused a delay in the review timeline. I will discuss that situation in more detail on slide nine. We no longer expect to conclude the review in the fourth quarter. We are targeting a conclusion of the strategic review in Q1 2027. I know this news is frustrating to you.

Dan KrawczykPresident and CEO

It is frustrating to me as well. But I assure you, we continue to advance the process to bring this review to a successful conclusion and move forward on a path that maximizes value for shareholders. Turning to Temiscaming on slide nine. The 50% U.S. tariff on Canadian paperboard took effect on August 22nd. Historically, approximately 70% of the site's paperboard production shipped to the U.S. That level of exposure made the tariff a significant change to the site's economics. We took mitigation steps during the third quarter, but despite those efforts, continued Paperboard & High Yield Pulp production was uneconomic. We economically idled production on October 3rd, and it remains idled. Essential site services continue to operate. We incurred $2 million in tariff-related costs during the third quarter. With production now idle, we estimate ongoing site carrying costs of $2 million-$3 million per month.

Dan KrawczykPresident and CEO

Our immediate focus is on managing those costs while evaluating all strategic options and working toward a definitive path forward for Temiscaming. Interested parties need to understand the potential path forward for Temiscaming, the ongoing costs, and the implications for the rest of the business. The conditions they are evaluating have changed. Our team has had to devote additional time and resources to managing the idling, evaluating the site's options, and providing the information and analysis needed to support that assessment. Together with the additional diligence parties are undertaking on Temiscaming, that work has slowed the review. We are working through those questions with interested parties and our advisors while diligence and discussions on the broader business continue. Parties remain engaged. Giving them a clear understanding of Temiscaming and the options for the site is a critical part of maximizing value through the review.

Dan KrawczykPresident and CEO

We want their assessment to reflect the full value of Rayonier Advanced Materials and the opportunities we see across the business. On slide 10, our priorities bring together the work on the business and the strategic review. First, advance the strategic review with interested parties and target a conclusion in Q1 2027. Second, execute our Cellulose Specialties leadership strategy. That means stronger customer partnerships, growing CS volumes, and capturing the value our products provide, supported by a production mix more heavily weighted towards CS and continued improvement in plant performance. Third, build on the sequential progress and work towards positive free cash flow for 2026. Achieving that objective requires disciplined working capital management, capital spending, and cost control, and remains subject to tariff-related cash impacts and Temiscaming's carrying costs. Fourth, exit 2026 with momentum. The progress in HPC continues to build and give us a better foundation.

FULL TRANSCRIPT

Continue the full translated transcript in StockNow.

Log in to unlock every statement, the English original, and speaker-by-speaker history.

Log in for the full transcript

Other earnings calls that day

View calls from this day